Literature DB >> 20636805

Programmed cell death of dendritic cells in immune regulation.

Min Chen1, Jin Wang.   

Abstract

Programmed cell death is essential for the maintenance of lymphocyte homeostasis and immune tolerance. Dendritic cells (DCs), the most efficient antigen-presenting cells, represent a small cell population in the immune system. However, DCs play major roles in the regulation of both innate and adaptive immune responses. Programmed cell death in DCs is essential for regulating DC homeostasis and consequently, the scope of immune responses. Interestingly, different DC subsets show varied turnover rates in vivo. The conventional DCs are relatively short-lived in most lymphoid organs, while plasmacytoid DCs are long-lived cells. Mitochondrion-dependent programmed cell death plays an important role in regulating spontaneous DC turnover. Antigen-specific T cells are also capable of killing DCs, thereby providing a mechanism for negative feedback regulation of immune responses. It has been shown that a surplus of DCs due to defects in programmed cell death leads to overactivation of lymphocytes and the onset of autoimmunity. Studying programmed cell death in DCs will shed light on the roles for DC turnover in the regulation of the duration and magnitude of immune responses in vivo and in the maintenance of immune tolerance.

Entities:  

Mesh:

Year:  2010        PMID: 20636805      PMCID: PMC3282617          DOI: 10.1111/j.1600-065X.2010.00916.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  179 in total

1.  Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells.

Authors:  H Matsue; D Edelbaum; A C Hartmann; A Morita; P R Bergstresser; H Yagita; K Okumura; A Takashima
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  A role for FADD in T cell activation and development.

Authors:  C M Walsh; B G Wen; A M Chinnaiyan; K O'Rourke; V M Dixit; S M Hedrick
Journal:  Immunity       Date:  1998-04       Impact factor: 31.745

3.  p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice.

Authors:  M Zörnig; A O Hueber; G Evan
Journal:  Curr Biol       Date:  1998-04-09       Impact factor: 10.834

4.  T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death.

Authors:  L Zheng; C L Trageser; D M Willerford; M J Lenardo
Journal:  J Immunol       Date:  1998-01-15       Impact factor: 5.422

Review 5.  Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment.

Authors:  M Lenardo; K M Chan; F Hornung; H McFarland; R Siegel; J Wang; L Zheng
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

6.  Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally.

Authors:  E E Varfolomeev; M Schuchmann; V Luria; N Chiannilkulchai; J S Beckmann; I L Mett; D Rebrikov; V M Brodianski; O C Kemper; O Kollet; T Lapidot; D Soffer; T Sobe; K B Avraham; T Goncharov; H Holtmann; P Lonai; D Wallach
Journal:  Immunity       Date:  1998-08       Impact factor: 31.745

7.  Blocked negative selection of developing T cells in mice expressing the baculovirus p35 caspase inhibitor.

Authors:  M Izquierdo; A Grandien; L M Criado; S Robles; E Leonardo; J P Albar; G G de Buitrago; C Martínez-A
Journal:  EMBO J       Date:  1999-01-04       Impact factor: 11.598

8.  Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer.

Authors:  R M Pitti; S A Marsters; D A Lawrence; M Roy; F C Kischkel; P Dowd; A Huang; C J Donahue; S W Sherwood; D T Baldwin; P J Godowski; W I Wood; A L Gurney; K J Hillan; R L Cohen; A D Goddard; D Botstein; A Ashkenazi
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

9.  A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis.

Authors:  K Y Yu; B Kwon; J Ni; Y Zhai; R Ebner; B S Kwon
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

10.  Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue.

Authors:  B Ludewig; B Odermatt; S Landmann; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

View more
  31 in total

1.  Transforming growth factor beta-activated kinase 1 (TAK1)-dependent checkpoint in the survival of dendritic cells promotes immune homeostasis and function.

Authors:  Yanyan Wang; Gonghua Huang; Peter Vogel; Geoffrey Neale; Boris Reizis; Hongbo Chi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

Review 2.  Molecular mechanisms involved in dendritic cell dysfunction in cancer.

Authors:  Michael Tang; Jun Diao; Mark S Cattral
Journal:  Cell Mol Life Sci       Date:  2016-08-05       Impact factor: 9.261

3.  Antitumor cytotoxicity induced by bone-marrow-derived antigen-presenting cells is facilitated by the tumor suppressor protein p53 via regulation of IL-12.

Authors:  Tania L Slatter; Michelle Wilson; Chingwen Tang; Hamish G Campbell; Vernon K Ward; Vivienne L Young; David Van Ly; Nicholas I Fleming; Antony W Braithwaite; Margaret A Baird
Journal:  Oncoimmunology       Date:  2015-12-17       Impact factor: 8.110

4.  Immune regulation through mitochondrion-dependent dendritic cell death induced by T regulatory cells.

Authors:  Min Chen; Kumar Felix; Jin Wang
Journal:  J Immunol       Date:  2011-10-26       Impact factor: 5.422

5.  Adenosine and cAMP signalling skew human dendritic cell differentiation towards a tolerogenic phenotype with defective CD8(+) T-cell priming capacity.

Authors:  John Challier; Denis Bruniquel; Andrew K Sewell; Bruno Laugel
Journal:  Immunology       Date:  2013-04       Impact factor: 7.397

6.  Single-cell phospho-specific flow cytometric analysis demonstrates biochemical and functional heterogeneity in human hematopoietic stem and progenitor compartments.

Authors:  Kenneth D Gibbs; Penney M Gilbert; Karen Sachs; Feifei Zhao; Helen M Blau; Irving L Weissman; Garry P Nolan; Ravindra Majeti
Journal:  Blood       Date:  2011-02-28       Impact factor: 22.113

7.  miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1.

Authors:  Changming Lu; Xin Huang; Xiaoxiao Zhang; Kristin Roensch; Qing Cao; Keiichi I Nakayama; Bruce R Blazar; Yan Zeng; Xianzheng Zhou
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

8.  IFN-α-Induced Downregulation of miR-221 in Dendritic Cells: Implications for HCV Pathogenesis and Treatment.

Authors:  Mohit Sehgal; Marija Zeremski; Andrew H Talal; Rashida Ginwala; Elizabeth Elrod; Arash Grakoui; Qi-Ging Li; Ramila Philip; Zafar K Khan; Pooja Jain
Journal:  J Interferon Cytokine Res       Date:  2015-06-19       Impact factor: 2.607

9.  Tuberous sclerosis 1 (Tsc1)-dependent metabolic checkpoint controls development of dendritic cells.

Authors:  Yanyan Wang; Gonghua Huang; Hu Zeng; Kai Yang; Richard F Lamb; Hongbo Chi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

10.  Inhibition of SIRPα in dendritic cells potentiates potent antitumor immunity.

Authors:  Qiong Liu; Wen Wen; Liang Tang; Chen-Jie Qin; Yan Lin; Hui-Lu Zhang; Han Wu; Charles Ashton; Hong-Ping Wu; Jin Ding; Wei Dong; Le-Xing Yu; Wen Yang; Dan-Dan Huang; Meng-Chao Wu; Hong-Yang Wang; He-Xin Yan
Journal:  Oncoimmunology       Date:  2016-08-23       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.